Compare Entergy Corporation (ETR) vs Hinge Health Inc. Class A Common Stock (HNGE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Entergy Corporation vs Hinge Health Inc. Class A Common Stock — how do they compare? Entergy Corporation trades at $103.92 (market cap $50.16B), while Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B). The key difference: Entergy Corporation is far larger — about 5.9× Hinge Health Inc. Class A Common Stock's market cap, and Entergy Corporation pays a 2.44% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Entergy Corporation for 13 Days and Hinge Health Inc. Class A Common Stock for 0 Days on average.
| ETR | HNGE | |
|---|---|---|
Market Cap | $50.16B | $8.48B |
Volume | 2,603,991 | 879,799 |
Sector | Utilities | Health |
52-Week High | $117.91 | $105.14 |
52-Week Low | $91.19 | $31.17 |
Typical Hold Time | 13 Days | 0 Days |
Enterprise Value | $80.94B | $8.10B |
Dividend Yield | 2.44% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Entergy Corporation (ETR) trades at $104.99, up 0.96% with a bullish technical signal despite overbought RSI readings. The stock shows strong fundamentals with 13.48% net margins and consistent earnings beats in recent quarters. Recent developments include $13.7M in federal grid funding and new data center agreements benefiting customers. Analyst consensus remains strongly positive with 59% buy ratings and a $123.17 price target representing 17% upside potential.
ETR presents a compelling investment case with stable utility operations, improving cash flows, and strategic grid investments. However, elevated valuation multiples and institutional selling activity warrant caution. The stock's proximity to resistance at $105 suggests near-term consolidation may precede further gains if earnings momentum continues through Q3 results.
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Entergy Corporation
Entergy is an energy company that operates regulated electric utilities and power generation businesses in the United States. Its generation portfolio includes nuclear, natural gas, and renewable resources.
Read more on ETR →About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →
